New and Special Drug
Aidaro (Ebdarokimab) – Psoriasis | HongKong DengYue Medicine
Zepsun (Donafenib Tosilate) – HCC | HongKong DengYue Medicine
Partruvix (Pamiparib) – gBRCA | HongKong DengYue Medicine
Nubeqa (Darolutamide) – Prostate Cancer | HongKong DengYue Medicine
Taiai (Telitacicept) – SLE | HongKong DengYue Medicine
Simponi (Golimumab) – IMIDs | HongKong DengYue Medicine
Esbriet (Pirfenidone) – IPF | HongKong DengYue Medicine
Stelara (Ustekinumab) – Immunomodulator | HongKong DengYue Medicine
Plaquenil (Hydroxychloroquine Sulfate) – Autoimmune | HongKong DengYue Medicine
FILSPARI (Sparsentan) – IgAN | HongKong DengYue Medicine
ORENITRAM (Treprostinil) – PAH | HongKong DengYue Medicine
Cystaran (Cysteamine Ophthalmic Solution) – Cystinosis | HongKong DengYue Medicine
FORTEO (Teriparatide) – Osteoporosis | HongKong DengYue Medicine
VYNDAMAX (Tafamidis) – ATTR-CM | HongKong DengYue Medicine
IMPLANON (Etonogestrel Implant) – Contraception | HongKong DengYue Medicine
EULEXIN (Flutamide) – Prostate Cancer | HongKong DengYue Medicine
